Innate Immunity Research for Emerging Infectious Diseases and Innovative Therapeutics

Jireh BioPath investigates the mechanisms underlying the pathogenesis and progression of emerging and re-emerging infectious diseases through innate immunity research, translating these discoveries into innovative therapeutic strategies and drug development.

Our immune system relies on a diverse array of innate immune sensors to defend against viral infections. However, excessive immune responses can cause severe inflammation and tissue damage, potentially leading to disease progression and life-threatening complications.

We aims to uncover the key regulatory mechanisms of these immune responses and establish a new therapeutic paradigm for the simultaneous control of infectious and inflammatory diseases.

Key Research Areas
RESEARCH AREA
Immune Mechanisms of Emerging and Re-emerging Infectious Diseases
We investigate host immune responses and pathogenic mechanisms using diverse viral infection models.
  • SARS-CoV-2
  • Herpes simplex Virus
  • Influenza Virus
  • Dengue Virus
  • Monkeypox Virus
  • Other Emerging Viruses
Diverse Viral Infection Models
Host Immune Responses & Signaling
Viral Pathogenesis
RESEARCH AREA
Innate Immune Sensors & Inflammatory Cell Death
We investigate the molecular mechanisms of innate immune sensing and inflammatory cell death activated during viral infection.
  • Innate immunity
  • Innate immune sensing signaling
  • Inflammasome signaling
  • Inflammatory cell death
  • Viral pathogenesis
  • Inflammation
Through this research, we aim to uncover key mechanisms driving disease progression and tissue damage and identify novel therapeutic targets.
Activation Mechanisms of Innate Immune Sensors, including AIM2 & ZBP1
Mechanisms of Inflammatory Cell Death
Key Mechanisms Driving Severe Disease and Mortality
RESEARCH AREA
Innovative Antiviral Therapeutics
Jireh BioPath is developing first-in-class therapeutics that selectively modulate innate immune sensors.
  • Small-Molecule Therapeutics
  • Host-Directed Therapy
  • Broad-Spectrum Antiviral Platform
  • Control of Excessive Inflammation
  • Reduction of Tissue Damage
  • Prevention of Disease Progression
Small-Molecule Therapeutics Targeting ZBP1 & AIM2
Selective Modulation of Innate Immune Sensors
Prevention of Severe Disease & Development of a Broad-Spectrum Antiviral Platform
ULTIMATE GOAL
ULTIMATE GOAL
Translating Scientific Discoveries into Therapeutics to Improve Human Health and Well-Being
Jireh BioPath aims to reduce the health and socioeconomic burden of infectious diseases and contribute to global health and sustainable health security by developing innovative therapeutic technologies to address future pandemic threats.